A meta-analysis of randomized trials that evaluated different doses of vitamin E in persons with liver disease concluded that supplementation may improve AST and ALT levels in cases of NASH and chronic hepatitis C, but not in NAFLD [64]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.